Ricardo Alvarez, MD
Family Practice · San Francisco
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 36 years
- University of Connecticut School of Medicine, 1990
On the public record
- California licence: Delinquent
Offices
2 locations · Mission Area Health Associates · 21 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp · Zuckerberg San Francisco General Hosp & Trauma Ctr. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alvarez’s office at (415) 852-4080 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G73709 · Delinquent
Licence status: Delinquent · since 1992 · expires 2026-03-31 · University of Connecticut School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
- Zuckerberg San Francisco General Hosp & Trauma CtrSan Francisco, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of San Francisco Health Network, which runs 2 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.449, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.37, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.538, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Zuckerberg San Francisco General Hosp & Trauma Ctr
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.449 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.37 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.538 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 667 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.76 to 1.49) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 195.34 (147.34 to 243.34) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.5 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 214 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 261 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,351 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.07 to 0.5) · 4,709 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.39 (0.19 to 0.59) · 4,644 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (2.11 to 6.56) · 795 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.28) · 234 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.85 (1.33 to 4.38) · 861 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.95 (0.25 to 17.64) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6 (2.01 to 9.98) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 167 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.79 (0.08 to 1.49) · 4,129 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.709 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.769 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 41 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 227 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 28.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 75.1 · 239 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (8.3 to 15.1) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 132 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.4 to 17.9) · 966 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.7) · 88 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,644 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Medicaid work
$51,290 in 2024
Medicaid paid $51,290 for 678 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 241 | $50,253 |
| Short return visit (20+ min) | 423 | $844 |
| Return visit (30+ min) | 14 | $193 |
| 2024 | 678 | 3 | 38 | $51,290 |
| 2023 | 663 | 3 | 29 | $47,464 |
| 2022 | 1,455 | 5 | 46 | $116,638 |
| 2021 | 2,631 | 5 | 55 | $216,639 |
| 2020 | 5,192 | 15 | 376 | $458,203 |
| 2019 | 8,647 | 15 | 316 | $683,026 |
| 2018 | 8,191 | 13 | 274 | $815,951 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 241 | $46,625 |
| Short return visit (20+ min) | 366 | $596 |
| Return visit (30+ min) | 56 | $243 |
2022
| Clinic visit/encounter, all-inclusive | 562 | $114,769 |
| Short return visit (20+ min) | 798 | $1,725 |
| Return visit (30+ min) | 57 | $108 |
| Hemoglobin A1C level | 12 | $19 |
| Short return visit | 26 | $16 |
2021
| Clinic visit/encounter, all-inclusive | 1,121 | $214,532 |
| Short return visit (20+ min) | 1,381 | $2,024 |
| Short return visit | 39 | $49 |
| Return visit (30+ min) | 74 | $34 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 16 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 2,338 | $452,315 |
| Short return visit (20+ min) | 1,280 | $2,648 |
| Return visit (30+ min) | 687 | $1,935 |
| Unclassified drugs | 12 | $851 |
| Short return visit | 212 | $319 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 65 | $87 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 174 | $29 |
| URINE PREGNANCY TEST | 51 | $8 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 51 | $6 |
| Hemoglobin A1C level | 78 | $5 |
| ANTEPARTUM CARE ONLY | 91 | $0 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 64 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 3,660 | $588,173 |
| Short return visit | 794 | $28,837 |
| Short return visit (20+ min) | 1,450 | $28,181 |
| Return visit (30+ min) | 1,135 | $23,234 |
| Unclassified drugs | 208 | $13,767 |
| URINE PREGNANCY TEST | 182 | $272 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 47 | $197 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 152 | $195 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 342 | $112 |
| Hemoglobin A1C level | 225 | $37 |
| Skin test; tuberculosis, intradermal | 37 | $10 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 100 | $6 |
2018
| Clinic visit/encounter, all-inclusive | 4,321 | $697,815 |
| Short return visit (20+ min) | 1,868 | $56,685 |
| Short return visit | 632 | $30,556 |
| Unclassified drugs | 310 | $23,449 |
| Return visit (30+ min) | 255 | $6,806 |
| URINE PREGNANCY TEST | 113 | $316 |
| OFF/OP EST MAY X REQ PHY/QHP | 266 | $152 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 172 | $113 |
| Hemoglobin A1C level | 153 | $43 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 24 | $12 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 20 | $4 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 45 | $0 |
Drugs they prescribed that Part D paid
$174,414
Pharmacies billed $174,414 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (75 of 2,025) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
1,773 generic and 232 brand-name prescriptions · $174,414 in drug cost · 18 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 19 | $22,469 | $1,183 |
| Jardiance | 16 | $18,166 | $1,135 |
| Farxiga | 15 | $10,242 | $683 |
| Lantus Solostar | 16 | $2,122 | $133 |
| Albuterol Sulfate Hfa | 29 | $1,845 | $64 |
See all 45 drugs
| Eliquis | 19 | $22,469 | $1,183 |
| Jardiance | 16 | $18,166 | $1,135 |
| Farxiga | 15 | $10,242 | $683 |
| Lantus Solostar | 16 | $2,122 | $133 |
| Albuterol Sulfate Hfa | 29 | $1,845 | $64 |
| Metoprolol | 83 | $1,622 | $20 |
| Atorvastatin | 145 | $1,039 | $7 |
| Omeprazole | 93 | $1,009 | $11 |
| Gabapentin | 56 | $829 | $15 |
| Diclofenac | 38 | $801 | $21 |
| Valsartan | 11 | $759 | $69 |
| Losartan | 99 | $601 | $6 |
| Hydrocodone-Acetaminophen | 23 | $552 | $24 |
| Levothyroxine | 43 | $549 | $13 |
| Metformin | 76 | $541 | $7 |
| Tamsulosin | 28 | $528 | $19 |
| Amlodipine Besylate | 96 | $509 | $5 |
| Famotidine | 32 | $393 | $12 |
| Fenofibrate | 26 | $369 | $14 |
| Pravastatin | 34 | $369 | $11 |
| Fluticasone Propionate | 41 | $357 | $9 |
| Metformin Hcl Er | 34 | $350 | $10 |
| Clopidogrel | 26 | $349 | $13 |
| Simvastatin | 31 | $335 | $11 |
| Duloxetine | 14 | $313 | $22 |
| Benazepril | 25 | $294 | $12 |
| Pantoprazole | 36 | $278 | $8 |
| Pioglitazone | 12 | $262 | $22 |
| Lisinopril | 37 | $251 | $7 |
| Glipizide | 23 | $212 | $9 |
| Atenolol | 17 | $202 | $12 |
| Finasteride | 17 | $152 | $9 |
| Hydralazine | 11 | $144 | $13 |
| Propranolol | 13 | $129 | $10 |
| Tramadol | 28 | $112 | $4 |
| Ibuprofen | 16 | $109 | $7 |
| Lorazepam | 19 | $99 | $5 |
| Meclizine | 18 | $91 | $5 |
| Citalopram Hbr | 12 | $85 | $7 |
| Hydrochlorothiazide | 31 | $84 | $3 |
| Sertraline | 16 | $77 | $5 |
| Trazodone | 11 | $75 | $7 |
| Furosemide | 18 | $74 | $4 |
| Alprazolam | 17 | $37 | $2 |
| Triamcinolone Acetonide | 11 | $33 | $3 |
Year by year
| 2024 | 2,025 | 280 | 4% (75) | 11% | $174,414 |
| 2023 | 1,732 | 246 | 3% (43) | 13% | $225,774 |
| 2022 | 2,087 | 144 | 2% (42) | 10% | $208,793 |
| 2021 | 2,773 | 161 | 2% (50) | 17% | $819,720 |
| 2020 | 2,035 | 151 | 4% (75) | 17% | $493,072 |
| 2019 | 1,418 | 112 | 4% (62) | 14% | $94,103 |
| 2018 | 1,280 | 104 | 5% (66) | 13% | $71,038 |
| 2017 | 1,360 | 113 | 3% (45) | 11% | $54,120 |
| 2016 | 1,633 | 124 | 3% (50) | 18% | $255,045 |
| 2015 | 2,068 | 117 | 3% (54) | 28% | $557,426 |
| 2014 | 2,253 | 117 | 1% (32) | 32% | $724,285 |
| 2013 | 2,935 | 115 | 1% (34) | None | $1,134,594 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 41 drugs
| Rybelsus | 13 | $29,047 | $2,234 |
| Eliquis | 19 | $25,731 | $1,354 |
| Januvia | 12 | $21,383 | $1,782 |
| Xarelto | 14 | $16,494 | $1,178 |
| Atorvastatin | 121 | $3,116 | $26 |
| Metoprolol | 73 | $1,915 | $26 |
| Gabapentin | 46 | $1,566 | $34 |
| Pioglitazone | 46 | $1,450 | $32 |
| Diclofenac | 41 | $1,391 | $34 |
| Levothyroxine | 50 | $1,356 | $27 |
| Metformin | 72 | $1,171 | $16 |
| Albuterol Sulfate Hfa | 23 | $1,011 | $44 |
| Losartan | 75 | $969 | $13 |
| Lisinopril | 56 | $892 | $16 |
| Amlodipine Besylate | 61 | $871 | $14 |
| Duloxetine | 15 | $772 | $51 |
| Omeprazole | 38 | $762 | $20 |
| Famotidine | 27 | $664 | $25 |
| Tamsulosin | 31 | $649 | $21 |
| Glipizide | 31 | $514 | $17 |
| Lisinopril-Hydrochlorothiazide | 35 | $482 | $14 |
| Clotrimazole | 26 | $434 | $17 |
| Glipizide Er | 14 | $371 | $27 |
| Pravastatin | 17 | $345 | $20 |
| Pantoprazole | 30 | $335 | $11 |
| Hydrochlorothiazide | 42 | $311 | $7 |
| Chlorthalidone | 18 | $296 | $16 |
| Simvastatin | 23 | $287 | $12 |
| Metformin Hcl Er | 18 | $273 | $15 |
| Fluticasone Propionate | 20 | $266 | $13 |
| Atenolol | 11 | $259 | $24 |
| Losartan-Hydrochlorothiazide | 13 | $255 | $20 |
| Ibuprofen | 15 | $248 | $17 |
| Citalopram Hbr | 14 | $220 | $16 |
| Benazepril | 12 | $185 | $15 |
| Meclizine | 13 | $182 | $14 |
| Fluoxetine | 16 | $178 | $11 |
| Furosemide | 24 | $166 | $7 |
| Paroxetine | 11 | $162 | $15 |
| Tramadol | 11 | $102 | $9 |
| Naproxen | 17 | $96 | $6 |
2022: 46 drugs
| Xarelto | 20 | $23,687 | $1,184 |
| Januvia | 12 | $20,265 | $1,689 |
| Eliquis | 12 | $19,180 | $1,598 |
| Victoza 3-Pak | 11 | $18,392 | $1,672 |
| Basaglar Kwikpen U-100 | 16 | $4,156 | $260 |
| Atorvastatin | 165 | $2,997 | $18 |
| Lantus Solostar | 11 | $2,833 | $258 |
| Duloxetine | 25 | $2,674 | $107 |
| Metoprolol | 99 | $2,652 | $27 |
| Gabapentin | 71 | $1,672 | $24 |
| Metformin | 118 | $1,346 | $11 |
| Omeprazole | 54 | $1,212 | $22 |
| Diclofenac | 50 | $1,089 | $22 |
| Tolterodine | 12 | $943 | $79 |
| Acetazolamide | 11 | $939 | $85 |
| Amlodipine Besylate | 89 | $909 | $10 |
| Lisinopril-Hydrochlorothiazide | 76 | $760 | $10 |
| Levothyroxine | 44 | $695 | $16 |
| Pioglitazone | 36 | $609 | $17 |
| Famotidine | 30 | $606 | $20 |
| Tamsulosin | 33 | $560 | $17 |
| Chlorthalidone | 26 | $550 | $21 |
| Hydrochlorothiazide | 74 | $498 | $7 |
| Glipizide | 45 | $495 | $11 |
| Lisinopril | 72 | $492 | $7 |
| Tramadol | 14 | $479 | $34 |
| Albuterol Sulfate Hfa | 21 | $432 | $21 |
| Fluticasone Propionate | 49 | $412 | $8 |
| Losartan | 47 | $404 | $9 |
| Carvedilol | 19 | $379 | $20 |
| Acyclovir | 15 | $361 | $24 |
| Ibuprofen | 26 | $348 | $13 |
| Citalopram Hbr | 16 | $284 | $18 |
| Pravastatin | 19 | $278 | $15 |
| Pantoprazole | 26 | $272 | $10 |
| Simvastatin | 24 | $269 | $11 |
| Oxybutynin Chloride | 17 | $246 | $14 |
| Furosemide | 38 | $221 | $6 |
| Meclizine | 11 | $151 | $14 |
| Benazepril | 13 | $149 | $11 |
| Hydromorphone | 12 | $145 | $12 |
| Acetaminophen-Codeine | 13 | $113 | $9 |
| Naproxen | 14 | $111 | $8 |
| Atenolol | 12 | $99 | $8 |
| Triamcinolone Acetonide | 17 | $77 | $5 |
| Clonazepam | 12 | $18 | $2 |
2021: 67 drugs
| Tivicay | 48 | $97,103 | $2,023 |
| Biktarvy | 23 | $83,656 | $3,637 |
| Triumeq | 22 | $73,765 | $3,353 |
| Descovy | 35 | $71,519 | $2,043 |
| Symtuza | 14 | $59,800 | $4,271 |
| Odefsey | 18 | $58,713 | $3,262 |
| Juluca | 12 | $38,229 | $3,186 |
| Januvia | 28 | $27,910 | $997 |
| Isentress | 12 | $22,410 | $1,868 |
| Eliquis | 19 | $17,530 | $923 |
| Xarelto | 13 | $13,361 | $1,028 |
| Emtriva | 12 | $6,806 | $567 |
| Atrovent Hfa | 11 | $5,026 | $457 |
| Flovent Hfa | 13 | $4,659 | $358 |
| Atorvastatin | 182 | $2,393 | $13 |
| Metoprolol | 117 | $1,851 | $16 |
| Omeprazole | 79 | $1,406 | $18 |
| Pilocarpine | 11 | $1,378 | $125 |
| Estradiol Valerate | 12 | $1,374 | $115 |
| Duloxetine | 12 | $1,262 | $105 |
| Acyclovir | 65 | $1,086 | $17 |
| Lantus Solostar | 12 | $1,084 | $90 |
| Gabapentin | 80 | $1,045 | $13 |
| Levothyroxine | 52 | $1,042 | $20 |
| Amlodipine Besylate | 133 | $995 | $7 |
| Metformin | 116 | $943 | $8 |
| Tolterodine | 13 | $941 | $72 |
| Albuterol Sulfate Hfa | 20 | $922 | $46 |
| Chlorthalidone | 29 | $828 | $29 |
| Diclofenac | 32 | $715 | $22 |
| Tamsulosin | 45 | $685 | $15 |
| Losartan | 83 | $659 | $8 |
| Famotidine | 43 | $643 | $15 |
| Ritonavir | 12 | $635 | $53 |
| Pioglitazone | 38 | $614 | $16 |
| Tramadol | 12 | $614 | $51 |
| Finasteride | 41 | $572 | $14 |
| Diphenoxylate-Atropine | 14 | $551 | $39 |
| Lisinopril | 87 | $549 | $6 |
| Lisinopril-Hydrochlorothiazide | 73 | $544 | $7 |
| Amitriptyline | 17 | $526 | $31 |
| Glipizide | 65 | $521 | $8 |
| Pravastatin | 27 | $471 | $17 |
| Pantoprazole | 22 | $376 | $17 |
| Hydrochlorothiazide | 73 | $365 | $5 |
| Ultra-Fine Mini Pen Needle | 11 | $361 | $33 |
| Ibuprofen | 38 | $360 | $9 |
| Fluticasone Propionate | 33 | $320 | $10 |
| Oxybutynin Chloride | 25 | $297 | $12 |
| Benazepril | 23 | $283 | $12 |
| Clotrimazole | 17 | $280 | $16 |
| Carvedilol | 21 | $265 | $13 |
| Citalopram Hbr | 33 | $254 | $8 |
| Simvastatin | 34 | $239 | $7 |
| Paroxetine | 13 | $220 | $17 |
| Hydralazine | 11 | $165 | $15 |
| Sertraline | 12 | $163 | $14 |
| Atenolol | 12 | $157 | $13 |
| Furosemide | 28 | $153 | $5 |
| Hydromorphone | 11 | $138 | $13 |
| Meclizine | 11 | $112 | $10 |
| Triamcinolone Acetonide | 17 | $104 | $6 |
| Acetaminophen-Codeine | 14 | $104 | $7 |
| Alendronate | 16 | $97 | $6 |
| Metformin Hcl Er | 22 | $72 | $3 |
| Allopurinol | 12 | $66 | $6 |
| Clonazepam | 12 | $22 | $2 |
2020: 53 drugs
| Symtuza | 19 | $77,469 | $4,077 |
| Tivicay | 32 | $67,639 | $2,114 |
| Biktarvy | 15 | $50,469 | $3,365 |
| Descovy | 16 | $37,392 | $2,337 |
| Isentress | 11 | $22,092 | $2,008 |
| Januvia | 16 | $18,393 | $1,150 |
| Oxycontin | 11 | $15,802 | $1,437 |
| Symbicort | 12 | $4,207 | $351 |
| Atorvastatin | 113 | $1,462 | $13 |
| Metoprolol | 67 | $1,347 | $20 |
| Diclofenac | 39 | $1,169 | $30 |
| Ventolin Hfa | 18 | $1,158 | $64 |
| Gabapentin | 71 | $1,054 | $15 |
| Chlorthalidone | 14 | $915 | $65 |
| Omeprazole | 54 | $781 | $14 |
| Amlodipine Besylate | 113 | $779 | $7 |
| Levothyroxine | 28 | $711 | $25 |
| Metformin | 72 | $659 | $9 |
| Quetiapine | 11 | $639 | $58 |
| Losartan | 53 | $605 | $11 |
| Testosterone Cypionate | 11 | $596 | $54 |
| Tamsulosin | 42 | $582 | $14 |
| Famotidine | 39 | $507 | $13 |
| Amitriptyline | 13 | $473 | $36 |
| Fluticasone Propionate | 32 | $443 | $14 |
| Hydrochlorothiazide | 57 | $404 | $7 |
| Pravastatin | 18 | $368 | $20 |
| Diphenoxylate-Atropine | 13 | $363 | $28 |
| Lisinopril-Hydrochlorothiazide | 44 | $362 | $8 |
| Clotrimazole | 21 | $361 | $17 |
| Acyclovir | 22 | $327 | $15 |
| Lisinopril | 47 | $323 | $7 |
| Pioglitazone | 17 | $316 | $19 |
| Carvedilol | 31 | $297 | $10 |
| Glipizide | 34 | $296 | $9 |
| Tramadol | 13 | $291 | $22 |
| Benazepril | 26 | $262 | $10 |
| Paroxetine | 18 | $210 | $12 |
| Ibuprofen | 25 | $168 | $7 |
| Pantoprazole | 15 | $160 | $11 |
| Meclizine | 11 | $153 | $14 |
| Hydromorphone | 11 | $143 | $13 |
| Allopurinol | 14 | $140 | $10 |
| Simvastatin | 23 | $133 | $6 |
| Furosemide | 22 | $118 | $5 |
| Finasteride | 14 | $112 | $8 |
| Atenolol | 12 | $109 | $9 |
| Citalopram Hbr | 17 | $107 | $6 |
| Acetaminophen-Codeine | 15 | $103 | $7 |
| Sertraline | 11 | $78 | $7 |
| Clonazepam | 15 | $73 | $5 |
| Isosorbide Mononitrate Er | 11 | $65 | $6 |
| Metformin Hcl Er | 17 | $63 | $4 |
2019: 38 drugs
| Basaglar Kwikpen U-100 | 19 | $8,416 | $443 |
| Symbicort | 14 | $4,490 | $321 |
| Pulmicort Flexhaler | 11 | $3,195 | $290 |
| Ventolin Hfa | 38 | $2,250 | $59 |
| Gabapentin | 41 | $1,956 | $48 |
| Metoprolol | 43 | $1,746 | $41 |
| Atorvastatin | 47 | $1,375 | $29 |
| Amlodipine Besylate | 85 | $919 | $11 |
| Metformin | 83 | $788 | $9 |
| Lisinopril-Hydrochlorothiazide | 49 | $585 | $12 |
| Tamsulosin | 30 | $577 | $19 |
| Omeprazole | 29 | $505 | $17 |
| Famotidine | 37 | $493 | $13 |
| Losartan | 33 | $474 | $14 |
| Fluticasone Propionate | 25 | $432 | $17 |
| Pravastatin | 12 | $418 | $35 |
| Levothyroxine | 16 | $401 | $25 |
| Pantoprazole | 15 | $354 | $24 |
| Pioglitazone | 14 | $339 | $24 |
| Lisinopril | 33 | $320 | $10 |
| Hydrochlorothiazide | 43 | $304 | $7 |
| Benazepril | 15 | $288 | $19 |
| Clotrimazole | 16 | $281 | $18 |
| Glipizide | 29 | $274 | $9 |
| Simvastatin | 27 | $258 | $10 |
| Paroxetine | 11 | $186 | $17 |
| Carvedilol | 18 | $173 | $10 |
| Ibuprofen | 21 | $159 | $8 |
| Hydromorphone | 12 | $150 | $13 |
| Meclizine | 12 | $121 | $10 |
| Clonazepam | 16 | $111 | $7 |
| Furosemide | 11 | $102 | $9 |
| Diazepam | 12 | $97 | $8 |
| Tramadol | 18 | $96 | $5 |
| Acetaminophen-Codeine | 14 | $95 | $7 |
| Metoprolol | 14 | $65 | $5 |
| Lorazepam | 12 | $22 | $2 |
| Promethazine | 11 | $16 | $1 |
2018: 36 drugs
| Basaglar Kwikpen U-100 | 16 | $6,623 | $414 |
| Pulmicort Flexhaler | 11 | $2,252 | $205 |
| Ventolin Hfa | 34 | $1,900 | $56 |
| Metoprolol | 37 | $1,624 | $44 |
| Atorvastatin | 49 | $832 | $17 |
| Gabapentin | 41 | $744 | $18 |
| Amlodipine Besylate | 71 | $586 | $8 |
| Metformin | 67 | $574 | $9 |
| Levothyroxine | 16 | $532 | $33 |
| Omeprazole | 40 | $487 | $12 |
| Tamsulosin | 19 | $432 | $23 |
| Famotidine | 41 | $418 | $10 |
| Pravastatin | 11 | $327 | $30 |
| Losartan | 28 | $301 | $11 |
| Fluticasone Propionate | 30 | $298 | $10 |
| Pioglitazone | 16 | $282 | $18 |
| Pantoprazole | 17 | $279 | $16 |
| Benazepril | 19 | $272 | $14 |
| Clotrimazole | 14 | $271 | $19 |
| Lisinopril-Hydrochlorothiazide | 47 | $236 | $5 |
| Donepezil | 13 | $224 | $17 |
| Glipizide | 27 | $222 | $8 |
| Hydrochlorothiazide | 29 | $206 | $7 |
| Carvedilol | 17 | $186 | $11 |
| Hydrocodone-Acetaminophen | 15 | $163 | $11 |
| Tramadol | 23 | $157 | $7 |
| Citalopram Hbr | 13 | $141 | $11 |
| Lisinopril | 23 | $132 | $6 |
| Clonazepam | 16 | $125 | $8 |
| Acetaminophen-Codeine | 17 | $124 | $7 |
| Metoprolol | 19 | $119 | $6 |
| Hydrocortisone | 17 | $116 | $7 |
| Furosemide | 17 | $109 | $6 |
| Simvastatin | 20 | $102 | $5 |
| Ibuprofen | 14 | $89 | $6 |
| Lorazepam | 16 | $25 | $2 |
2017: 40 drugs
| Lantus Solostar | 22 | $8,350 | $380 |
| Testosterone | 11 | $2,563 | $233 |
| Fluocinonide | 11 | $1,307 | $119 |
| Metoprolol | 29 | $1,269 | $44 |
| Pravastatin | 23 | $958 | $42 |
| Atorvastatin | 59 | $909 | $15 |
| Ventolin Hfa | 11 | $583 | $53 |
| Gabapentin | 47 | $518 | $11 |
| Metformin | 74 | $491 | $7 |
| Levothyroxine | 14 | $479 | $34 |
| Omeprazole | 57 | $462 | $8 |
| Ultra-Fine Short Pen Needle | 11 | $429 | $39 |
| Testosterone Cypionate | 11 | $378 | $34 |
| Famotidine | 47 | $331 | $7 |
| Pioglitazone | 21 | $330 | $16 |
| Amlodipine Besylate | 48 | $323 | $7 |
| Tamsulosin | 14 | $308 | $22 |
| Benazepril | 27 | $216 | $8 |
| Hydrochlorothiazide | 35 | $178 | $5 |
| Lisinopril-Hydrochlorothiazide | 42 | $174 | $4 |
| Simvastatin | 27 | $157 | $6 |
| Lisinopril | 42 | $151 | $4 |
| Furosemide | 27 | $148 | $5 |
| Paroxetine | 16 | $143 | $9 |
| Losartan | 17 | $140 | $8 |
| Ibuprofen | 27 | $138 | $5 |
| Metoprolol | 21 | $122 | $6 |
| Trazodone | 16 | $122 | $8 |
| Fluticasone Propionate | 13 | $121 | $9 |
| Hydroxyzine | 13 | $118 | $9 |
| Atenolol | 22 | $117 | $5 |
| Carvedilol | 13 | $106 | $8 |
| Glipizide | 19 | $103 | $5 |
| Hydrocortisone | 15 | $95 | $6 |
| Acetaminophen-Codeine | 12 | $88 | $7 |
| Nortriptyline | 11 | $81 | $7 |
| Sertraline | 12 | $78 | $7 |
| Clonazepam | 13 | $54 | $4 |
| Tramadol | 13 | $53 | $4 |
| Lorazepam | 12 | $19 | $2 |
2016: 48 drugs
| Truvada | 23 | $34,008 | $1,479 |
| Isentress | 23 | $29,783 | $1,295 |
| Prezista | 14 | $19,057 | $1,361 |
| Norvir | 26 | $10,577 | $407 |
| Lantus Solostar | 13 | $4,885 | $376 |
| Levemir Flextouch | 11 | $4,564 | $415 |
| Testosterone | 12 | $3,602 | $300 |
| Flovent Hfa | 11 | $1,805 | $164 |
| Metoprolol | 38 | $1,769 | $47 |
| Pravastatin | 41 | $1,406 | $34 |
| Fluocinonide | 13 | $1,385 | $107 |
| Omeprazole | 81 | $994 | $12 |
| Benazepril-Hydrochlorothiazide | 11 | $983 | $89 |
| Tamsulosin | 24 | $979 | $41 |
| Atorvastatin | 42 | $968 | $23 |
| Testosterone Cypionate | 24 | $917 | $38 |
| Bd Ultra-Fine Pen Needle | 17 | $624 | $37 |
| Metformin | 78 | $556 | $7 |
| Amlodipine Besylate | 69 | $475 | $7 |
| Famotidine | 39 | $426 | $11 |
| Benazepril | 34 | $414 | $12 |
| Pioglitazone | 21 | $404 | $19 |
| Clotrimazole | 16 | $331 | $21 |
| Hydrocodone-Acetaminophen | 20 | $317 | $16 |
| Ibuprofen | 41 | $282 | $7 |
| Simvastatin | 29 | $277 | $10 |
| Duloxetine | 12 | $276 | $23 |
| Furosemide | 23 | $245 | $11 |
| Losartan | 23 | $239 | $10 |
| Meclizine | 13 | $230 | $18 |
| Hydrochlorothiazide | 43 | $230 | $5 |
| Gabapentin | 22 | $211 | $10 |
| Lisinopril-Hydrochlorothiazide | 42 | $207 | $5 |
| Fluticasone Propionate | 26 | $196 | $8 |
| Glipizide | 28 | $184 | $7 |
| Acyclovir | 19 | $183 | $10 |
| Metoprolol | 25 | $176 | $7 |
| Carvedilol | 13 | $175 | $13 |
| Lisinopril | 29 | $153 | $5 |
| Diazepam | 13 | $153 | $12 |
| Atenolol | 22 | $132 | $6 |
| Naproxen | 25 | $128 | $5 |
| Donepezil | 11 | $126 | $11 |
| Acetaminophen-Codeine | 18 | $123 | $7 |
| Terazosin | 11 | $123 | $11 |
| Hydrocortisone | 16 | $114 | $7 |
| Clonazepam | 16 | $74 | $5 |
| Nortriptyline | 12 | $55 | $5 |
2015: 61 drugs
| Truvada | 78 | $106,501 | $1,365 |
| Reyataz | 43 | $55,824 | $1,298 |
| Isentress | 43 | $52,640 | $1,224 |
| Epzicom | 29 | $42,277 | $1,458 |
| Triumeq | 17 | $36,667 | $2,157 |
| Stribild | 14 | $35,549 | $2,539 |
| Prezista | 23 | $28,841 | $1,254 |
| Norvir | 79 | $26,424 | $334 |
| Atripla | 12 | $26,141 | $2,178 |
| Sustiva | 21 | $17,713 | $843 |
| Intelence | 11 | $11,333 | $1,030 |
| Lexiva | 11 | $11,078 | $1,007 |
| Nevirapine Er | 12 | $6,797 | $566 |
| Cevimeline | 12 | $4,710 | $392 |
| Tamsulosin | 26 | $2,470 | $95 |
| Pravastatin | 76 | $2,176 | $29 |
| Metoprolol | 33 | $1,934 | $59 |
| Hydrocodone-Acetaminophen | 43 | $1,571 | $37 |
| Testosterone Cypionate | 32 | $1,569 | $49 |
| Diphenoxylate-Atropine | 34 | $1,274 | $37 |
| Benazepril-Hydrochlorothiazide | 14 | $1,263 | $90 |
| Proair Hfa | 16 | $980 | $61 |
| Omeprazole | 74 | $773 | $10 |
| Bupropion Hcl Sr | 18 | $681 | $38 |
| Famotidine | 58 | $604 | $10 |
| Atorvastatin | 22 | $580 | $26 |
| Fluconazole | 11 | $557 | $51 |
| Amlodipine Besylate | 80 | $533 | $7 |
| Megestrol Acetate | 19 | $531 | $28 |
| Gabapentin | 37 | $519 | $14 |
| Acyclovir | 38 | $506 | $13 |
| Levothyroxine | 18 | $505 | $28 |
| Metformin | 83 | $426 | $5 |
| Meclizine | 24 | $424 | $18 |
| Duloxetine | 11 | $384 | $35 |
| Ibuprofen | 53 | $382 | $7 |
| Doxazosin Mesylate | 13 | $356 | $27 |
| Benazepril | 40 | $278 | $7 |
| Hydrochlorothiazide | 47 | $273 | $6 |
| Hydralazine | 14 | $223 | $16 |
| Azithromycin | 11 | $219 | $20 |
| Cyclobenzaprine | 12 | $218 | $18 |
| Lisinopril | 34 | $205 | $6 |
| Pantoprazole | 17 | $196 | $12 |
| Losartan | 17 | $194 | $11 |
| Simvastatin | 21 | $186 | $9 |
| Fluticasone Propionate | 22 | $186 | $8 |
| Lisinopril-Hydrochlorothiazide | 30 | $150 | $5 |
| Clonazepam | 13 | $148 | $11 |
| Clopidogrel | 12 | $147 | $12 |
| Terazosin | 13 | $147 | $11 |
| Atenolol | 19 | $141 | $7 |
| Trazodone | 21 | $130 | $6 |
| Metoprolol | 23 | $126 | $5 |
| Carvedilol | 12 | $115 | $10 |
| Naproxen | 14 | $108 | $8 |
| Topiramate | 11 | $107 | $10 |
| Glipizide | 17 | $99 | $6 |
| Escitalopram | 12 | $91 | $8 |
| Diazepam | 18 | $75 | $4 |
| Citalopram Hbr | 21 | $66 | $3 |
2014: 66 drugs
| Truvada | 84 | $108,325 | $1,290 |
| Isentress | 63 | $71,951 | $1,142 |
| Epzicom | 57 | $68,987 | $1,210 |
| Reyataz | 47 | $58,637 | $1,248 |
| Atripla | 22 | $53,059 | $2,412 |
| Stribild | 18 | $44,304 | $2,461 |
| Prezista | 29 | $33,235 | $1,146 |
| Sustiva | 42 | $31,778 | $757 |
| Norvir | 91 | $31,590 | $347 |
| Mepron | 12 | $19,658 | $1,638 |
| Intelence | 17 | $15,863 | $933 |
| Lexiva | 15 | $14,254 | $950 |
| Kaletra | 12 | $12,614 | $1,051 |
| Viramune Xr | 17 | $10,937 | $643 |
| Androgel | 19 | $7,599 | $400 |
| Duloxetine | 17 | $2,750 | $162 |
| Testosterone Cypionate | 42 | $2,276 | $54 |
| Pravastatin | 70 | $2,066 | $30 |
| Metoprolol | 20 | $1,285 | $64 |
| Bupropion Hcl Sr | 27 | $1,110 | $41 |
| Naltrexone | 11 | $1,074 | $98 |
| Proair Hfa | 21 | $1,043 | $50 |
| Fluconazole | 15 | $1,010 | $67 |
| Amlodipine Besylate | 82 | $871 | $11 |
| Atorvastatin | 20 | $811 | $41 |
| Acyclovir | 45 | $804 | $18 |
| Gabapentin | 40 | $774 | $19 |
| Diphenoxylate-Atropine | 36 | $759 | $21 |
| Omeprazole | 53 | $705 | $13 |
| Metformin | 60 | $686 | $11 |
| Benazepril | 66 | $648 | $10 |
| Famotidine | 75 | $641 | $9 |
| Fluocinonide | 12 | $604 | $50 |
| Tamsulosin | 18 | $602 | $33 |
| Hydrocodone-Acetaminophen | 26 | $592 | $23 |
| Cyproheptadine | 12 | $587 | $49 |
| Ondansetron | 12 | $582 | $48 |
| Levothyroxine | 26 | $552 | $21 |
| Hydralazine | 12 | $519 | $43 |
| Megestrol Acetate | 14 | $455 | $33 |
| Nevirapine | 14 | $445 | $32 |
| Doxazosin Mesylate | 14 | $425 | $30 |
| Azithromycin | 13 | $334 | $26 |
| Hydrochlorothiazide | 67 | $317 | $5 |
| Fluticasone Propionate | 19 | $284 | $15 |
| Ibuprofen | 35 | $272 | $8 |
| Prochlorperazine Maleate | 16 | $262 | $16 |
| Latanoprost | 17 | $257 | $15 |
| Meclizine | 14 | $242 | $17 |
| Naproxen | 18 | $214 | $12 |
| Pantoprazole | 11 | $213 | $19 |
| Cyclobenzaprine | 13 | $213 | $16 |
| Amitriptyline | 29 | $194 | $7 |
| Simvastatin | 23 | $193 | $8 |
| Lisinopril | 31 | $193 | $6 |
| Paroxetine | 13 | $182 | $14 |
| Metoprolol | 24 | $179 | $7 |
| Glipizide | 19 | $171 | $9 |
| Lisinopril-Hydrochlorothiazide | 15 | $164 | $11 |
| Hydrocortisone | 27 | $152 | $6 |
| Glyburide | 14 | $127 | $9 |
| Warfarin | 12 | $116 | $10 |
| Citalopram Hbr | 36 | $115 | $3 |
| Atenolol | 16 | $111 | $7 |
| Trazodone | 15 | $106 | $7 |
| Alendronate | 14 | $99 | $7 |
2013: 72 drugs
| Truvada | 147 | $183,193 | $1,246 |
| Isentress | 120 | $128,186 | $1,068 |
| Reyataz | 98 | $109,373 | $1,116 |
| Atripla | 42 | $94,988 | $2,262 |
| Epzicom | 73 | $76,162 | $1,043 |
| Norvir | 193 | $66,047 | $342 |
| Prezista | 53 | $57,366 | $1,082 |
| Trizivir | 34 | $55,213 | $1,624 |
| Neupogen | 13 | $41,685 | $3,207 |
| Viread | 46 | $38,985 | $848 |
| Lexiva | 40 | $35,160 | $879 |
| Kaletra | 34 | $31,717 | $933 |
| Sustiva | 46 | $30,550 | $664 |
| Viramune Xr | 34 | $20,689 | $608 |
| Intelence | 21 | $18,193 | $866 |
| Invirase | 12 | $11,433 | $953 |
| Abacavir | 25 | $10,304 | $412 |
| Viracept | 11 | $9,592 | $872 |
| Lamivudine-Zidovudine | 19 | $9,526 | $501 |
| Androgel | 24 | $7,826 | $326 |
| Ondansetron | 16 | $2,630 | $164 |
| Nevirapine | 25 | $1,906 | $76 |
| Gabapentin | 65 | $1,796 | $28 |
| Bupropion Hcl Sr | 30 | $1,632 | $54 |
| Pravastatin | 95 | $1,467 | $15 |
| Acyclovir | 82 | $1,354 | $17 |
| Testosterone Cypionate | 24 | $1,273 | $53 |
| Atorvastatin | 32 | $1,170 | $37 |
| Diphenoxylate-Atropine | 52 | $1,104 | $21 |
| Omeprazole | 64 | $1,091 | $17 |
| Naltrexone | 11 | $1,077 | $98 |
| Fluconazole | 13 | $1,008 | $78 |
| Metoprolol | 23 | $931 | $40 |
| Megestrol Acetate | 12 | $814 | $68 |
| Benazepril | 90 | $758 | $8 |
| Famotidine | 70 | $681 | $10 |
| Hydrocodone-Acetaminophen | 28 | $660 | $24 |
| Metformin | 52 | $577 | $11 |
| Amlodipine Besylate | 49 | $570 | $12 |
| Proair Hfa | 12 | $559 | $47 |
| Dapsone | 11 | $453 | $41 |
| Azithromycin | 13 | $434 | $33 |
| Paroxetine | 32 | $379 | $12 |
| Loperamide | 13 | $374 | $29 |
| Pantoprazole | 12 | $318 | $27 |
| Fluticasone Propionate | 17 | $314 | $18 |
| Levothyroxine | 28 | $305 | $11 |
| Simvastatin | 25 | $280 | $11 |
| Hydrochlorothiazide | 56 | $278 | $5 |
| Glyburide | 13 | $275 | $21 |
| Glipizide | 22 | $272 | $12 |
| Meclizine | 16 | $271 | $17 |
| Metoprolol | 32 | $262 | $8 |
| Citalopram Hbr | 42 | $261 | $6 |
| Naproxen | 20 | $241 | $12 |
| Warfarin | 24 | $236 | $10 |
| Cyclobenzaprine | 12 | $231 | $19 |
| Ibuprofen | 31 | $222 | $7 |
| Trazodone | 30 | $212 | $7 |
| Lisinopril | 34 | $187 | $5 |
| Zolpidem | 31 | $187 | $6 |
| Gemfibrozil | 13 | $174 | $13 |
| Amitriptyline | 32 | $174 | $5 |
| Montelukast | 11 | $153 | $14 |
| Sertraline | 11 | $133 | $12 |
| Baclofen | 16 | $111 | $7 |
| Fluoxetine | 11 | $93 | $8 |
| Doxazosin Mesylate | 13 | $91 | $7 |
| Hydrocortisone | 13 | $70 | $5 |
| Lorazepam | 12 | $63 | $5 |
| Clonazepam | 12 | $62 | $5 |
| Atenolol | 11 | $56 | $5 |
Money from drug and device companies
$68 in 2025
| 2025 | 1 | 1 | None | $68 |
| 2020 | 1 | 1 | None | $11 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | Trodelvy | $68 | 1 payment
|
See the published payment
| Gilead Sciences | Meals · 2025-06-02 | Trodelvy | $68 |
See earlier years (2020)
2020: $11
| Eisai | Lenvima | $11 | 1 payment
|
Professional record
- NPI
- 1649352626
- Licence
- CA G73709California G73709: Delinquent · expires 2026-03-31
- Trained
- University of Connecticut School of Medicine, 1990 · 36 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207QA0505X (207QA0505X)
- Mailing address
- 240 Shotwell St, San Francisco, CA, 94110
- NPI first listed
- 2006-10-19
- NPI last updated
- 2011-11-23
This is when the NPI record was last certified, not a medical board exam.